Edison Partners Exits RapidDeploy To Motorola Solutions
Growth equity firm Edison Partners announced today the exit of its investment in RapidDeploy to Motorola Solutions, the leading provider of cloud-native next-generation 911 mapping, mobile and analytics solutions for public safety agencies. Financial terms were not disclosed. Read Motorola Solutions' announcement here.
The Austin, TX-based company empowers public safety agencies across the United States with real-time intelligence to enhance emergency response and decision-making. RapidDeploy's cloud-native solutions integrate with an ecosystem of partners and applications, connecting millions of data points to deliver critical, life-saving information to public safety centers. Since 2016, RapidDeploy's technology has expanded to serve over one thousand six hundred 911 centers across 23 states, with 13 statewide contracts, democratizing public safety with cloud-native SaaS solutions.
'We are so pleased with the growth trajectory and strategic opportunity for RapidDeploy after making our initial $20M growth investment in 2023. We recognized that RapidDeploy had a unique ability to lead in a historically challenging space for new entrants,' said Chris Sugden, managing partner at Edison Partners. 'With the support of Edison's value creation resources, including Edison Director Network member Jo Kinsella, to advance the company's market leadership position, RapidDeploy CEO Steve Raucher and his team have taken the company to new heights and, with their state-of-the-art NextGen 911 technology, they've made our country's emergency response system stronger.'
RapidDeploy represents one of multiple portfolio companies that support Edison's investment thesis around digitizing critical infrastructure. Two additional recent investments supporting this theme include a $15M investment made in Seismos, an AI-driven technology firm using sound to make energy production safer, cleaner and more efficient, and a $43M growth investment in 120Water, a digital water solution helping the country's 50,000 state and local water utilities to protect public health through water safety, compliance, and wastewater monitoring programs. Further, in 2021, Edison invested in Recycle Track Systems which provides on-demand refuse removal to fully integrated waste management solutions, helping companies and municipalities easily track and optimize their services.
+1.917.287.3626
SOURCE: Edison Partners
Copyright Business Wire 2025.
PUB: 02/24/2025 07:11 AM/DISC: 02/24/2025 07:11 AM
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Top 3 Retail REITs to Watch as Industry Sentiment Strengthens
The Zacks REIT and Equity Trust - Retail industry constituents are well-positioned to capitalize on favorable market conditions and evolving strategies. Strong consumer spending and limited new development underpin healthy fundamentals, while high-performing retail hubs continue to attract tenants. The relevance of physical retail remains strong, supported by omnichannel models and experience-driven formats. Companies like Brixmor Property Group Inc. BRX, Phillips Edison & Company, Inc. PECO and Urban Edge Properties UE are poised to benefit. However, ongoing e-commerce expansion, shifting trade policies and elevated interest rates pose notable headwinds. These pressures may lead to tighter margins, increased financing costs and a potential uptick in store closures, underscoring the importance of a strategic tenant mix and capital discipline. Industry Description The Zacks REIT and Equity Trust - Retail industry comprises REITs that own, develop, manage and lease various retail properties, including regional malls, outlet centers, grocery-anchored shopping venues and power centers with big-box retailers. Net lease REITs focus on freestanding properties, where tenants bear rent and most operating expenses. Retail REIT performance is significantly impacted by economic conditions, employment levels and consumer spending trends. Key drivers of demand include the geographic location of properties and the demographics of surrounding trade areas. While the industry faced significant challenges from declining foot traffic, store closures and retailer bankruptcies in the past, it is now experiencing a rebound, driven by renewed consumer interest in in-store shopping, signaling a positive shift in the retail landscape. What's Shaping the Future of the REIT and Equity Trust - Retail Industry? Experiential Retail and Omnichannel Integration Are Revitalizing the Sector: Retail REITs are benefiting from the transformation of physical stores into immersive, experience-driven destinations. Experiential retail, incorporating dining, entertainment and interactive elements, is driving stronger foot traffic, longer visit durations and higher sales. This evolution aligns with changing consumer preferences that favor engagement over transactional shopping. Complementing this trend is the growth of omnichannel strategies, as retailers, including digitally-native brands, are establishing physical storefronts to reduce return costs and deepen customer relationships. Programs like Buy Online, Return In Store ('BORIS') enhance convenience while boosting in-store traffic. Another key tailwind is solid leasing demand from consumer service providers and cross-border entrants expanding into U.S. markets. These tenant categories have shown resilience amid macroeconomic uncertainty, helping diversify the tenant base and drive long-term occupancy stability. Altogether, these factors are reinforcing the importance of brick-and-mortar assets in a digitally integrated retail Supply and Strategic Revamps Support Fundamentals: Retail REITs are also benefiting from a structurally constrained supply pipeline. New construction remains limited due to elevated building costs, labor shortages and stricter financing conditions — factors that are unlikely to reverse quickly. As a result, national vacancy rates remain historically tight. This low supply environment supports continued rent growth, especially in prime locations. Many REITs are capitalizing on this low-supply environment by redeveloping and repurposing underperforming assets, often adding non-traditional tenants such as healthcare services, gyms or entertainment venues. Mixed-use developments are also gaining momentum, turning outdated retail sites into vibrant, community-oriented destinations. These strategies are reinforcing portfolio durability and improving rental income visibility across economic Volatility, E-Commerce Pressure and Tariffs Cast Shadows: Despite positive structural shifts, retail REITs face ongoing pressure from macroeconomic headwinds. High interest rates, inflation and tariff changes are prompting retailers to delay leasing decisions or scale back expansion plans. Store closures are now outpacing openings, and leasing activity is slowing. Rising e-commerce penetration dampens demand for traditional retail space, especially in commodity-driven segments. Tariffs on low-cost imports could further erode retailer profitability, limiting expansion plans and increasing the likelihood of further bankruptcies, leading to vacancy risk and challenging cash flow visibility for retail REITs in the near term. Zacks Industry Rank Indicates Bright Prospects The Zacks REIT and Equity Trust - Retail industry is housed within the broader Zacks Finance sector. It carries a Zacks Industry Rank #69, which places it in the top 28% of around 250 Zacks industries. The group's Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates robust near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. The industry's positioning in the top 50% of the Zacks-ranked industries is a result of the upward funds from operations (FFO) per share outlook for the constituent companies in aggregate. Looking at the aggregate FFO per share estimate revisions, it appears that analysts are gaining confidence in this group's growth potential. Since March 2025, the industry's FFO per share estimates for 2025 and 2026 have moved 1.64% and 0.2% north, respectively. Before we present a few stocks that you may want to consider for your portfolio, let's take a look at the industry's recent stock market performance and valuation picture. Industry Underperforms Sector and S&P 500 The REIT and Equity Trust - Retail Industry has underperformed the broader Zacks Finance sector and the S&P 500 composite over the past year. The industry has declined 5.5% during this period compared with the S&P 500's rise of 19.4% and the broader Finance sector's growth of 19.1%. One-Year Price PerformanceIndustry's Current Valuation On the basis of the forward 12-month price-to-FFO, which is a commonly used multiple for valuing retail REITs, we see that the industry is currently trading at 14.62X compared with the S&P 500's forward 12-month price-to-earnings (P/E) of 22.54X. The industry is also trading below the Finance sector's forward 12-month P/E of 16.71X. These are shown in the chart below. Forward 12 Month Price-to-FFO (P/FFO) Ratio Over the last five years, the industry has traded as high as 18.89X and as low as 12.21X, with a median of 15.19X. 3 Retail REIT Stocks to Consider Brixmor: Headquartered in New York, this REIT focuses on the ownership and management of open-air shopping centers across the United States. Its portfolio features a well-balanced tenant base that includes flourishing national, regional and local shopping centers are strategically positioned near residential areas, offering convenient access and supporting last-mile distribution. The portfolio features a balanced tenant mix, combining non-discretionary and value-focused retailers with consumer-focused service providers, enhancing foot traffic and ensuring consistent demand across a variety of economic currently carries a Zacks Rank #2 (Buy). Over the past month, the Zacks Consensus Estimate for the current-year FFO per share has witnessed a marginal upward revision to $2.23, indicating a 4.7% year-over-year jump. The stock has also risen 3.7% over the past three months. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Phillips Edison: PECO, based in Cincinnati, OH, specializes in the ownership and operation of high-quality, grocery-anchored neighborhood shopping centers. As of June 30, 2025, the company managed 327 shopping centers, including 303 wholly owned centers containing 34.0 million square feet across 31 states and 24 shopping centers owned in three institutional joint offers omnichannel grocery-anchored shopping experiences. It enjoys strong-credit neighbors and a diversified mix. With high-quality, necessity-based tenants and resilient foot traffic trends, PECO benefits from consistent demand. It is also among the REITs with the lowest tenant exposure to changes in tariff rates. Strong tenant retention, solid same store net operating growth, decent lease spreads, and consistent dividend income underscore its operational excellence and long-term value currently carries a Zacks Rank #2. Over the past month, the Zacks Consensus Estimate for 2025 FFO per share has witnessed a 1.2% upward revision to $2.58, reflecting analysts' bullish outlook. Though the stock has declined 5.6% over the past three months, it currently offers a good entry point. Urban Edge Properties: This New York-based company is engaged in the owning, managing, acquiring, developing and redeveloping retail real estate in urban communities, primarily in the Washington, DC to Boston corridor. Its properties are concentrated in the most densely populated, supply-constrained region in the country, assuring a steady flow of a large portion of Urban Edge's portfolio is anchored by high-performing essential retailers, which ensures stable cash flows. Particularly, 80% of portfolio value is grocery-anchored. It has a healthy balance sheet, with only 8% of debt maturing through 2026. It targets long-term FFO growth of 4-5% annually, supported by a strong lease pipeline (≈9% of NOI) and strategic redevelopment and capital currently has a Zacks Rank #2. The Zacks Consensus Estimate for its 2025 FFO per share has been raised 1.4% over the past month to $1.40, indicating a 3.7% year-over-year increase. The stock has rallied 6.8% in the past three months. Note: Funds from operations (FFO) is a widely used metric to gauge the performance of REITs rather than net income as it indicates cash flow from their operations. FFO is obtained after adding depreciation and amortization to earnings and subtracting the gains on sales. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Urban Edge Properties (UE) : Free Stock Analysis Report Brixmor Property Group Inc. (BRX) : Free Stock Analysis Report Phillips Edison & Company, Inc. (PECO) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
4 days ago
- Yahoo
HistoSonics宣布被頂尖投資人聯盟以22.5億美元收購
HistoSonics Edison組織摧毀術系統影片（影片來源：HistoSonics） HistoSonics非侵入性Edison組織摧毀術系統（圖片來源：HistoSonics） 圖片來源：HistoSonics 此次收購將加快公司突破性Edison®組織摧毀術平台及非侵入性腫瘤療法的全球擴張 明尼亞波里斯, August 08, 2025--(BUSINESS WIRE)--(美國商業資訊)--Edison®組織摧毀術系統及新型組織摧毀術治療平台的研發企業HistoSonics今日宣布，由一批全球知名的私人和公共投資人組成的聯盟將以管理層主導的方式收購其多數股權，投資方包括K5 Global、Bezos Expeditions、Wellington Management以及其他新投資人和現有投資人。此次交易對HistoSonics的估值約為22.5億美元，將協助公司加快Edison系統在新臨床適應症及全球市場的成長。 HistoSonics將繼續由總裁兼執行長Mike Blue及其管理團隊領導。交易完成後，Blue先生還將擔任董事長一職。 Blue先生表示：「身為一家公司，我們始終專注於速度、規模，以及為病患提供比現有方案更優選擇的迫切使命。這批新合作夥伴支援那些定義品類、變革整個產業的企業。他們的支援將為我們注入動力，加大發展動力，擴大至新的臨床適應症，嘉惠全球更多亟需我們突破性療法的病患。」 HistoSonics計畫在初始聚焦的肝腫瘤之外，將業務擴充至腎、胰腺和攝護腺腫瘤適應症，其長期願景是讓組織摧毀術應用於全身多種臨床場景，同時治療良性和惡性疾病。 K5 Global共同創辦人兼管理合夥人Bryan Baum表示：「HistoSonics的亮點不僅在於技術，更在於團隊將突破性成果轉化為實際臨床進展的速度和清晰度。醫院持續訂購系統，病患需求激增，臨床結果不言自明。我們選擇與HistoSonics合作，是因為這是罕見的科學、執行力與商機完美契合的時刻，我們將協助其療法嘉惠全球每一家醫院。」 HistoSonics成立于2009年，於2023年10月獲得美國食品藥物管理局(FDA)的De Novo核准，它採用非侵入性聚焦超音波能量，在亞細胞層面以機械方式摧毀並液化目標群組織和腫瘤，且沒有傳統手術的侵入性或毒性。 截至目前，全美50多家頂尖醫療中心已使用Edison系統治療超過2000名病患，預計年底前還將安裝50套系統。憑藉在肝、腎、胰腺、攝護腺等多個器官系統的廣泛臨床前和臨床研究，公司目前正在招募肝腫瘤、腎腫瘤（HOPE4KIDNEY試驗，NCT05820087）和胰腺腫瘤（GANNON試驗，NCT06282809）的臨床試驗病患，並計畫在近期啟動其他試驗。 參與此次交易的其他投資方包括頂尖全球投資機構，如Alpha JWC Ventures，以及現有投資人Alpha Wave Ventures、Venture Investors Health Fund、Lumira Ventures、Hatteras Venture Partners、Early Stage Partners、Amzak Health、HealthQuest Capital、Yonjin Venture、威斯康辛州投資委員會、密西根州退休系統，以及透過其企業創投部門Johnson & Johnson - JJDC, Inc. (JJDC)參與其中的Johnson & Johnson等。 Citi擔任HistoSonics的財務顧問，Fox Rothschild擔任其法律顧問。Morgan Stanley & Co. LLC擔任投資聯盟的財務顧問，Cooley在Orrick的協助下擔任其法律顧問。Wilson Sonsini Goodrich & Rosati擔任HistoSonics現有主要股東的法律顧問。 HistoSonics 公司概覽 HistoSonics是一家私人醫療器材公司，利用組織摧毀術開發非侵入性平台和專有聲束療法。組織摧毀術是一種利用聚焦超音波以機械方式破壞和液化多餘組織和腫瘤的新型作用機制。該公司目前專注於在美國和部分全球市場將其用於肝臟治療的Edison系統商業化，同時將組織摧毀術的應用擴充到腎臟、胰腺、攝護腺等其他器官。HistoSonics在密西根州安娜堡和明尼蘇達州明尼亞波里斯設有辦事處。如欲瞭解有關Edison組織摧毀術系統的更多資訊，請造訪： 免責聲明：本公告之原文版本乃官方授權版本。譯文僅供方便瞭解之用，煩請參照原文，原文版本乃唯一具法律效力之版本。 請前往 瀏覽源版本: Contacts 媒體連絡人： Josh King 行銷副總裁 608.332.8124 Kimberly Ha KKH Advisors 917-291-5744
Business Upturn
4 days ago
- Business Upturn
HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors
Business Wire India HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced a management-led majority stake acquisition by a syndicate of globally recognized private and public investors, including K5 Global, Bezos Expeditions, Wellington Management and other new and existing investors. The transaction values HistoSonics at approximately $2.25 billion and positions the company for accelerated growth of the Edison System across new clinical indications and global markets. This press release features multimedia. View the full release here: HistoSonics Non-Invasive Edison Histotripsy System Image credit: HistoSonics HistoSonics will continue to be led by President and Chief Executive Officer, Mike Blue, and his executive team. Mr. Blue will also assume the role of Chairman of the Board upon closing. 'Our relentless focus as a company has been speed, scale, and the urgency to offer patients a better option than any they have today,' said Mr. Blue. 'This new group of partners backs category-defining companies that transform entire industries. Their support gives us the firepower to accelerate our momentum, expand into new clinical indications, and reach even more patients around the world who urgently need our breakthrough therapy.' HistoSonics plans to expand beyond its initial focus on liver tumors to kidney, pancreas, and prostate indications, with a long-term vision of histotripsy being used across a wide range of clinical applications throughout the body, treating both benign and malignant conditions. 'What stood out with HistoSonics wasn't just the technology, it was the speed and clarity with which the team turned a breakthrough into real clinical traction,' said Bryan Baum, Co-Founder and Managing Partner, K5 Global. 'Hospitals are continuing to order systems, patient demand is surging, and the clinical results speak for themselves. We partnered with HistoSonics because this is one of those rare moments where the science, the execution, and the opportunity all align, and we are here to ensure it reaches every hospital in the world.' HistoSonics, founded in 2009, received FDA De Novo clearance in October 2023 and uses non-invasive focused ultrasound energy to mechanically destroy and liquify targeted tissue and tumors at a sub-cellular level and without the invasiveness or toxicity of traditional procedures. To date, over 2,000 patients have been treated by the Edison system at over 50 leading U.S. medical centers, with another 50 planned system installations by year-end. Supported by extensive preclinical and clinical research across multiple organ systems, including liver, kidney, pancreas, prostate and others, the company is currently enrolling patients in clinical trials for liver tumors, kidney tumors (HOPE4KIDNEY Trial NCT05820087) and pancreas tumors (GANNON Trial NCT06282809), with plans to start others in the near future. Additional participants in the transaction include top‑tier global investment firms, including Alpha JWC Ventures, alongside existing investors Alpha Wave Ventures, Venture Investors Health Fund, Lumira Ventures, Hatteras Venture Partners, Early Stage Partners, Amzak Health, HealthQuest Capital, Yonjin Venture, the State of Wisconsin Investment Board, the State of Michigan Retirement System, Johnson & Johnson through its corporate venture capital organization, Johnson & Johnson – JJDC, Inc. (JJDC), and others. Citi served as financial advisor and Fox Rothschild served as legal advisor to HistoSonics. Morgan Stanley & Co. LLC served as financial advisor and Cooley, with assistance from Orrick, served as legal advisors to the investment syndicate. Wilson Sonsini Goodrich & Rosati served as legal advisor to Histosonics' existing major shareholders. About HistoSonics HistoSonics is a privately held medical device company developing a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumors. The company is currently focused on commercializing their Edison System in the US and select global markets for liver treatment while expanding histotripsy applications into other organs like kidney, pancreas, prostate, and others. HistoSonics has offices in Ann Arbor, MI and Minneapolis, MN. For more information on the Edison Histotripsy System please visit: For patient-related information please visit: View source version on Disclaimer: The above press release comes to you under an arrangement with Business Wire India. Business Upturn take no editorial responsibility for the same. Ahmedabad Plane Crash
